elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38594117-5B36F69D-3FE6-4EB3-83B6-CB979A35BB6A
Q38594117-5B36F69D-3FE6-4EB3-83B6-CB979A35BB6A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38594117-5B36F69D-3FE6-4EB3-83B6-CB979A35BB6A
Flibanserin: First Global Approval.
P2860
Q38594117-5B36F69D-3FE6-4EB3-83B6-CB979A35BB6A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38594117-5B36F69D-3FE6-4EB3-83B6-CB979A35BB6A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
32dd2da5bd6d62bee9d800ff8c63c148c0e7ed28
P2860
Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.